Casa asdas

Disease Control Data, nr-axSpA

Por um escritor misterioso

Last updated 02 junho 2024

Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.

Extra-articular manifestations and burden of disease in patients with radiographic and non-radiographic axial spondyloarthritis.

Overview of Ankylosing Spondylitis, Clinical Guidance

Disease Control Data, nr-axSpA

Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis

A Road Map of the Axial Spondyloarthritis Continuum - ScienceDirect

Axial Spondyloarthritis (axSpA) Market Size, Share, Growth And Forecast 2032

IJMS, Free Full-Text

Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria - Fabian Proft, Denis Poddubnyy, 2018

Frontiers Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis

A flow diagram of SpA patients in Asian countries versus non-Asian

Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review, BMC Musculoskeletal Disorders

The impact of gender and sex on diagnosis, treatment outcomes and health-related quality of life in patients with axial spondyloarthritis

Recomendado para você